REMINDER: Our focusIR Investor Webinar takes place TONIGHT with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 186.20
Bid: 186.00
Ask: 186.20
Change: -0.20 (-0.11%)
Spread: 0.20 (0.108%)
Open: 186.00
High: 186.60
Low: 185.20
Prev. Close: 186.40
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SBTi approval for near-term and net-zero targets

21 Feb 2024 07:00

RNS Number : 8397D
Essentra plc
21 February 2024
 

ESSENTRA PLC

 

("Essentra" or the "Company")

 

Essentra receives SBTi approval for near-term and net-zero targets

 

Essentra plc, a leading global provider of essential components and solutions, today announces that the Science Based Targets initiative ("SBTi") has approved Essentra's near and long-term science-based emissions reduction targets including verification of Essentra's net-zero science-based target by 2050. The approval demonstrates a key milestone in the Company's sustainability strategy, and progress and commitment towards the Company's vision of being the world's leading responsible hassle-free supplier of essential industrial components.

 

The SBTi's Target Validation Team has reviewed Essentra's scope 1, ?2 and 3 near-term target ambitions, and determined that they are in line with a 1.5°C trajectory. The Target Validation Team has also evaluated Essentra's scope 1, 2 and 3 long-term target ambitions, and determined that the long-term targets are aligned with the SBTi's 1.5°C mitigation pathways for reaching net-zero by 2050 or sooner.

 

Near-Term Targets:

· Essentra commits to reduce absolute scope 1 and 2 GHG emissions by 50% by 2030 from a 2019 base year.

· Essentra also commits to reduce scope 3 GHG emissions from purchased goods and services and upstream transportation and distribution by 55% per GBP of value added by 2030 from a 2022 base year.

 

Long-Term Targets:

· Essentra commits to reduce absolute scope 1 and 2 GHG emissions by 90% by 2040 from a 2019 base year.

· Essentra also commits to reduce absolute scope 3 emissions by 90% by 2050 from a 2022 base year.

 

Overall Net-Zero Target:  Essentra commits to reach net-zero greenhouse gas emissions across the value chain by 2050.

 

Essentra's 2022 Annual Report showed that the Company is already making good progress against these targets, having reduced scope 1 and 2 emissions by 27% and emissions intensity by 35% since 2019, as it transitions to renewable electricity and an increased focus on energy management programmes. Essentra has developed a climate transition plan to provide full transparency on how it plans to deliver against these targets. This will be included in the 2023 Annual Report, to be published in April 2024.

 

Jennifer Spence, Head of Sustainability Strategy at Essentra said:

 

"Delivering a sustainable service for our customers, our people and the planet sits at the heart of Essentra's ESG strategy, and achieving approval of our emissions reduction targets from the SBTi is a significant milestone in our journey, emphasising our commitment to decarbonisation. Our first year as a pure-play components business has allowed us to sharpen our focus on ESG topics which will drive the Company towards our goal of building a sustainable future, and in 2024 we will be publishing our first climate transition plan which will detail our roadmap to net-zero."

 

 

Enquiries

Essentra plc

Claire Goodman, Investor Relations Manager

Jennifer Spence, Head of Sustainability

Emma Reid, Company Secretary

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes over 3,000 employees, 13 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.74,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

About the Science Based Targets initiative

The Science Based Targets initiative ("SBTi") is a global body enabling businesses to set ambitious emissions reductions targets in line with the latest climate science. It is focused on accelerating companies across the world to halve emissions before 2030 and achieve net-zero emissions before 2050.

The initiative is a collaboration between CDP, the United Nations Global Compact, World Resources Institute ("WRI") and the World Wide Fund for Nature ("WWF") and one of the We Mean Business Coalition commitments. The SBTi defines and promotes best practice in science-based target setting, offers resources and guidance to reduce barriers to adoption, and independently assesses and approves companies' targets.

www.sciencebasedtargets.org

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRATMMJTMTJTTAI
Date   Source Headline
29th Apr 20222:18 pmRNSHolding(s) in Company
26th Apr 202210:42 amRNSHolding(s) in Company
21st Apr 202211:57 amRNSHolding(s) in Company
11th Apr 20224:00 pmRNSAnnual Report and Accounts and Notice of AGM
4th Apr 20224:17 pmRNSHolding(s) in Company
4th Apr 20229:55 amRNSDirectorate Change
1st Apr 20229:25 amRNSTotal Voting Rights
18th Mar 20227:00 amRNSResults for the Full Year Ended 31 December 2021
14th Mar 20227:00 amRNSDirectorate Change
4th Mar 202211:00 amRNSInvitation to FY 2021 Results Presentation
1st Mar 20229:52 amRNSTotal Voting Rights
8th Feb 202212:00 pmRNSNotice of Results
1st Feb 20229:02 amRNSTotal Voting Rights
7th Jan 20227:00 amRNSFY 2021 Pre-close trading update
4th Jan 20227:58 amRNSTotal Voting Rights
20th Dec 202111:13 amRNSResult of AGM
17th Dec 20217:46 amRNSTotal Voting Rights
26th Nov 20217:00 amRNSStrategic Update and Directorate Change
22nd Nov 202110:32 amRNSHolding(s) in Company
3rd Nov 20217:00 amRNSTotal Voting Rights
26th Oct 20217:00 amRNSStrategic Update and Q3 2021 Trading
1st Oct 20218:13 amRNSTotal Voting Rights
2nd Sep 202111:36 amRNSTotal Voting Rights
13th Aug 20217:00 amRNSAppointment of Board Trainee
3rd Aug 20217:00 amRNSCompletion of Components Acquisition in China
2nd Aug 20217:00 amRNSTotal Voting Rights
30th Jul 20217:00 amRNSResults for the Half Year Ended 30 June 2021
20th Jul 202112:00 pmRNSInvitation to HY 2021 Results Presentation
7th Jul 20217:00 amRNSHY 2021 Pre-Close Trading Update
1st Jul 20217:50 amRNSChange of Registered Office
1st Jul 20217:48 amRNSTotal Voting Rights
28th Jun 20214:02 pmRNSDirectorate Change
25th Jun 20215:01 pmRNSAppointment of a Non-Executive Director
2nd Jun 20218:25 amRNSTotal Voting Rights
28th May 20213:38 pmRNSHolding(s) in Company
20th May 202112:30 pmRNSResult of AGM
20th May 20217:00 amRNSAGM 2021 Trading Update
18th May 20217:25 amRNSDirector Declaration
13th May 20217:00 amRNSComponents Acquisition in China
4th May 202111:21 amRNSTotal Voting Rights
21st Apr 20217:00 amRNSHolding(s) in Company
16th Apr 20217:00 amRNS1st Quarter Results
9th Apr 202111:00 amRNSForthcoming Q1 2021 Trading Update
1st Apr 20214:17 pmRNSDirector/PDMR Shareholding - Replacement
1st Apr 20213:59 pmRNSDirector/PDMR Shareholding
1st Apr 20213:56 pmRNSDirector/PDMR Shareholding
1st Apr 20213:54 pmRNSDirector/PDMR Shareholding
1st Apr 202110:10 amRNSTotal Voting Rights
30th Mar 20212:53 pmRNSDirector/PDMR Shareholding
30th Mar 202112:24 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.